Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asha Pillai

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiencyBrandon M Triplett, Chong Wang, Jie Yang, et al.
JAMA Network Open|April 4, 2025
Gender Inequity in Institutional Leadership Roles in US Academic Medical Centers: A Systematic Scoping ReviewMorgan S Levy, Kelby N Hunt, Kara A Lindsay, et al.
Veterinary Pathology|May 13, 2017
Globule Leukocytes and Other Mast Cells in the Mouse IntestinePeter Vogel, Laura Janke, David M Gravano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemiaAshok Srinivasan, John C Panetta, Shane J Cross, et al.
Blood|May 27, 2011
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWing Leung, Dario Campana, Jie Yang, et al.
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
Cancer Treatment and Research Communications|July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapyRolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Oncogene|June 14, 2022
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerJashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiencyBrandon M Triplett, Chong Wang, Jie Yang, et al.
JAMA Network Open|April 4, 2025
Gender Inequity in Institutional Leadership Roles in US Academic Medical Centers: A Systematic Scoping ReviewMorgan S Levy, Kelby N Hunt, Kara A Lindsay, et al.
Veterinary Pathology|May 13, 2017
Globule Leukocytes and Other Mast Cells in the Mouse IntestinePeter Vogel, Laura Janke, David M Gravano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemiaAshok Srinivasan, John C Panetta, Shane J Cross, et al.
Blood|May 27, 2011
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWing Leung, Dario Campana, Jie Yang, et al.
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
Cancer Treatment and Research Communications|July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapyRolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Oncogene|June 14, 2022
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerJashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Pageof 3